Duke-NUS study shows promise for heart muscle regeneration

Biologics |  News | 0 Comment | 25 Mar, 2019

Researchers at Duke-NUS Medical School, Singapore, have developed an approach to regenerate heart muscle using stem cells. Their method for priming stem cells to become heart tissues could ...Read more

NUS researchers develop self-healing electronic skin

Biologics |  News | 0 Comment | 22 Mar, 2019

Scientists from National University of Singapore (NUS) have taken inspiration from underwater invertebrates like jellyfish to create an electronic skin with similar functionality. Just lik...Read more

Fujifilm to acquire Biogen in a $890 M deal

Biologics |  News | 0 Comment | 13 Mar, 2019

FUJIFILM Corporation ("Fujifilm") announced that it has entered into an agreement to acquire Biogen (Denmark) Manufacturing ApS, a large-scale biologics manufacturing site located in Hiller...Read more

Ambrx, BeiGene to develop next-generation biologics

Biologics |  News | 0 Comment | 08 Mar, 2019

Ambrx Inc., a clinical-stage biopharmaceutical company focused on the development of innovative protein therapeutics and BeiGene, Ltd., a commercialstage biopharmaceutical company focused o...Read more

Study: Inflammation in the brain enhances the side-effects of hypnotic medication

Biologics |  News | 0 Comment | 06 Mar, 2019

In a study recently published in the European Journal of Pharmacology researchers at Okayama University show how the presence of inflammation in the brain can increase its sensiti...Read more

Duke-NUS team reveals unknown mechanisms of zika infection

Biologics |  News | 0 Comment | 05 Mar, 2019

Researchers at Duke-NUS Medical School and their colleagues have identified a surprising interaction between dengue and Zika viruses that sheds lights on the significant fetal brain abnorma...Read more

Data sharing uncovers five new risk genes for Alzheimer’s disease

Biologics |  News | 0 Comment | 04 Mar, 2019

Analysis of genetic data from more than 94,000 individuals has revealed five new risk genes for Alzheimer’s disease, and confirmed 20 known others. An international team of researche...Read more

Adagene to evaluate dynamic precision library platform with Celgene

Biologics |  Regulatory | 0 Comment | 04 Mar, 2019

China based Adagene, Inc., an innovative antibody discovery and engineering company, has announced a multi-target platform evaluation with Celgene Corporation. Under the terms of the agreem...Read more

Link between GSL antigens and tumor survival in breast cancer found in a new research

Biologics |  News | 0 Comment | 19 Feb, 2019

A team led by Dr. Chi-Huey Wong, Distinguished Research Fellow, Academia Sinica in Taiwan, in collaboration with OBI scientists, has demonstrated in a recent study that the Globo-series gly...Read more

Chipscreen Biosciences unites with Innovent for colorectal cancer therapy

Biologics |  News | 0 Comment | 18 Feb, 2019

Chipscreen Biosciences, a leading integrated Chinese biotech company specialized in discovery and development of novel small molecule pharmaceuticals with a primary focus in oncology, metab...Read more

Singapore researchers reveal role of anti-parasitic drug in treating cancer

Biologics |  News | 0 Comment | 15 Feb, 2019

Scientists from A*STAR’s Institute of Molecular and Cell Biology (IMCB) have discovered that niclosamide, an FDA-approved anti-parasitic drug, can effectively kill p53-defective cance...Read more

Researchers develop potential therapeutic model for Parkinson’s disease

Biologics |  News | 1 Comment | 12 Feb, 2019

Parkinson's disease (PD) is the second most common neurodegenerative disorder, implicating 10 million people worldwide but has no cure at present. The main reason for this is the difficulty...Read more

Duke-NUS researchers reveal novel immune study on dengue

Biologics |  News | 0 Comment | 08 Feb, 2019

Researchers at Duke-NUS Medical School have demonstrated for the first time a physical interaction between two types of immune cells that plays an important role in the early fight against ...Read more

NUS researchers study nanoparticles’ role in cancer metastasis

Biologics |  News | 0 Comment | 04 Feb, 2019

Nanoparticles can be found in processed food (e.g. food additives), consumer products (e.g. sunscreen) and even in medicine. While these tiny particles could have large untapped potential a...Read more

Researchers in Japan develop strategy to strengthen skeletal muscles

Biologics |  News | 0 Comment | 01 Feb, 2019

Hokkaido University researchers have developed a strategy to fabricate materials that become stronger in response to mechanical stress mimicking skeletal muscle growth. Their findings could...Read more

Alvotech raises $300mn to further biosimilar development

Biologics |  News | 0 Comment | 24 Jan, 2019

Alvotech has successfully raised US$300 million through a private bond offering. Net proceeds from the capital raised will be used to fuel continued growth, refinance of existing debt and...Read more

Novel device by NUS aids in muscle recovery

Biologics |  News | 0 Comment | 24 Jan, 2019

A team of NUS researchers has developed a novel medical device capable of harnessing a magnetic field to make muscle rehabilitation quicker and more comfortable. MRegen is a non-invasive p...Read more

I-Mab Biopharma gets USFDA IND nod for antibody TJD5

Biologics |  News | 0 Comment | 23 Jan, 2019

China-based clinical stage biopharmaceutical company, I-Mab Biopharma, exclusively focused on the development of innovative biologics in immuno-oncology and autoimmune diseases, announ...Read more